Cannabis Report
Home > Boards > US OTC > Medical - Healthcare >

BioCorRx (BICX)

BICX RSS Feed
Add BICX Price Alert      Hide Sticky   Hide Intro
Moderator: Pip611, Swisher27
Search This Board: 
Last Post: 9/21/2018 2:49:30 PM - Followers: 143 - Board type: Free - Posts Today: 0

 

 

About BioCorRx

Program Overview

BioCorRx (OTCBB: BICX) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a treatment program that is used by various licensed alcohol addiction clinics throughout the United States.

The program consists of two components:BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant formulation of the FDA-approved drug, naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol for as long as a year in some patients, depending on individual metabolism rates.BioCorRx also owns a life coaching program that is tailored specifically to alcoholics. Once a patient has received the implant, they are encouraged to enter the life coaching program to maximize results.

BioCorRx’s revolutionary alcohol treatment program has an 85% success rate as reported by patients in routine telephone and face to face interviews. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life coaching program without co-workers or family members knowing, unless they so choose.

Technology

Naltrexone is a medication that blocks the effects of drugs known as opioids and was approved by the FDA in 1995 for the treatment of alcohol dependence.

Learn more about the side effects of naltrexone.

Naltrexone blocks the parts of the brain that "feel pleasure” when patients use alcohol. When these areas of the brain are blocked, patients feel significantly less cravings for alcohol and even if alcohol is used, the effects of it will be extremely limited - making sobriety the only option. Once medical intervention has reduced the physical need for alcohol, the program goes on to address the patient's psychological needs. The combination of these treatments has resulted in the highest chance of sobriety.

naltrexone implant

While other companies use naltrexone in their treatments, the drug is typically administered in oral or injection form, requiring their patients to be responsible for taking the medication or scheduling an appointment.

While some patients do well with the oral formulation, there is a drawback that it must be taken daily and a patient whose craving becomes overwhelming can obtain the euphoria simply by skipping a dose before resuming abuse. Patients who received the program developed by BioCorRx are treated with a slow release dose that can last up to year in many patients (depending on various factors such as metabolism rates), which gives the patients a higher success rate for the treatment of alcoholism.

The outpatient naltrexone implant procedure can take as little as 20 minutes under local anesthetic in some cases. Most patients can return to work or their daily routine in the same day, without the cravings for alcohol.

Mission, Vision, Values

Mission

BioCorRx is focused on providing leadership and innovation for the treatment of alcoholism by offering a high-quality, comprehensive and cost-effective recovery program that allows patients and their loved ones to celebrate freedom from the cycle of alcohol addiction. Our program is built on a strong foundation of experience and practice, allowing for an improved quality of life for recovering alcoholics.

Vision

BioCorRx strives to be the preeminent, long-term alcohol recovery program used by treatment centers around the world for alcoholics, as well as their family and friends. By providing patients a "Fresh Start" on life, they have the opportunity to live happier, healthier, more productive lives away from the damaging impact of alcohol. We have built an organization that is committed to nurturing research for cutting-edge alcohol recovery technologies and integrating those technologies with comprehensive alcohol recovery treatment programs.

Values

BioCorRx provides the opportunity and tools to treatment centers so they can help patients live happier, healthier, and more productive lives to those suffering from alcohol addiction (as well as their family and friends) by helping them break the addiction cycle and live alcohol-free. We want patients to celebrate freedom from the past and hope for the future. Our team consists of physicians, coaches, founders and management that are committed to providing high-quality services and adherence to ethical care.

Our goal is to give our treatment center partners the ability to deliver our program in a timely, warm and compassionate way to give patients, as well as their families and friends, peace of mind. To achieve this, BioCorRx has built its program around highly-qualified alcohol addiction specialists and effective treatment solutions.

We are committed to quality and continuous improvement in order to meet our partners’ needs for an individualized program dedicated to alcohol addiction recovery.

Investors Overview

BioCorRx is uniquely poised to gain significant market share of the $22 billion annual alcohol treatment market in the US.

More than 7% of the US population ages 18 years and older or 13.8 million Americans have problems with drinking, including 8.1 million people who suffer from alcoholism. And the costs financially are staggering. Alcohol dependency and abuse costs the US over $220 billion a year. For the sake of comparison, this is greater than the amount of money spent to combat cancer ($196 billion) and obesity ($133 billion).

BioCorRx intends to distribute the program to a new clinic in the United States every 60 to 90 days. Clinics using our program are also holding discussions with major health insurance providers to pay for all or a portion of the treatment fees.

Business Model

BioCorRx’s research has discovered that demand for its services are high and that growth in highly marketed segments of the population may be achieved through partnering with additional clinic sites. The company is also exploring the sub-licensing of the program to select regions of the US and internationally.

BioCorRx's goal is to meet its growth targets through licensing opportunities by promoting its naltrexone implant product and counseling service model to existing medical clinics and treatment centers that will purchase the program and/or product from the company. In addition, Fresh Start Private intends to open corporately owned clinics in select key markets where it is deemed appropriate.

Stock Price & Charts

BioCorRx is a fully reporting company. Financial reports and other reports are available for view or by visiting the OTCBB.com online website. Audited financial reports are available quarterly.

Company Structure Details

  • Legal name: BioCorRx
    Sector: Healthcare
    Industry: Specialized Health Services
    Full Time Employees: 4
    Public Company: SEC Reporting and fully audited
    Symbol: BICX
    Exchange: OTCBB
    Outstanding: 117,800,000
    Authorized: 200,000,000
    CUSIP: 35804J102
    NAICS Code: 623220
    SIC Number: 8093
    Transfer Agent: Columbia Stock Transfer Company, 1869 E. Seltice Way #292, Post Falls, ID 83854 Tel (208) 664-3544
    CIK: 0001443863
    EIN: 26-1972677
    Year End: December 31
    State of incorporation: Nevada
    Products: Alcohol rehabilitation, exclusive naltrexone implant technology
    Address: 601 North Parkcenter Drive, Suite 103, Santa Ana, CA 92705 USA
    Investors: 858-381-4677
    Email: investors@biocorrx.com
    Website: www.biocorrx.com
Watch Jeremy Miller on Fox News!
https://www.youtube.com/watch?v=kVKgWi3_t5Y

<iframe width="560" height="315" src="; frameborder="0" allowfullscreen></iframe>www.youtube.com/embed/xhJrYqsV0VQ

<iframe width="560" height="315" src="https://www.youtube.com/watch?v=kVKgWi3_t5Y" frameborder="0" allowfullscreen></iframe>


 

BICX Chart

Key Executives

Kent Emry - CEO, Director
Brady Granier -COO, Director
Lourdes Felix -CFO, Director
Dr. Jorge Andrade, Jr. - Director
Neil Muller -Co-Founder and President, Director 

Locations
Locations of independently owned clinics using our Fresh Start Program

Start Fresh Recovery
720 N. Tustin Ave.
Suite 206
Santa Ana, CA 92705
714-541-6100
800-916-1099
www.startfreshrecovery.com 
www.stopdrinkingUSA.com

Start Fresh Executive Recovery
367 E Virginia Ave
Phoenix, AZ 85004
855-393-HOPE (4673)
www.ExecutiveRecovery.net 

Fresh Start Private Florida
1415 Panther Lane
Suites 313-320
Naples, FL 34109
800-985-7574
www.FreshStartPrivateFlorida.com 

Start Fresh Alcohol Recovery Center
2827 S. 88th St
Omaha NE 68124
402-884-1221
www.startfreshNE.com

Coming Soon!

• San Francisco, California
• Chandler, Arizona
• North Scottsdale, Arizona
• Connecticut

Insider Interview Links

December 2, 2013 - thewallstreetanalyzer.com Interview with Brady Granier COO
November 14, 2013 - SmallCapVoice Interview with Kent Emry CEO
October 2, 2013 - SmallCapVoice Interview with Brady Granier COO

 

 

Cannabis Report
BICX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#7544  Sticky Note VIVITROL is injectable naltrexone produced by Alkermes plc Pip611 09/09/16 05:15:47 PM
#11642   Also from that same article in August: Swisher27 09/21/18 02:49:30 PM
#11641   There was a NR about when they expect Swisher27 09/21/18 02:47:44 PM
#11640   read the last few PRs. They mentioned Pip611 09/21/18 02:24:25 PM
#11639   So when do you think BICX will see big orange 09/21/18 02:15:44 PM
#11638   Strongly disagree. The company needs to continue as Swisher27 09/21/18 01:42:36 PM
#11637   BICX probly won't get a grant. I big orange 09/21/18 12:32:19 PM
#11636   Another week gone by..... msw1221 09/21/18 11:30:54 AM
#11635   That's A LOT of buying !!!!!! DREAM BIG 09/18/18 03:48:23 PM
#11634   Having similar thoughts. Swisher27 09/18/18 02:01:32 PM
#11633   Stock moving. Maybe news of the grant leaked??? Pip611 09/18/18 01:28:19 PM
#11632   New to this forum, and I have been A_Bourla 09/18/18 12:56:25 PM
#11631   Isn't that what bicx product does? Why big orange 09/18/18 09:56:38 AM
#11630   Let's hope BICX is next. Admtiger 09/17/18 07:11:23 PM
#11629   Good find! And even more disappointing is that Kizersosae 09/17/18 03:49:37 PM
#11628   “Titan Awarded NIDA Grant For The Development Of Leshrac528 09/17/18 01:21:06 PM
#11627   Well.... Hopefully big money this week.. Nathans123 09/16/18 05:17:15 PM
#11626   SHOW ME THE MONEY!! :):) Fido 09/15/18 01:10:51 PM
#11625   Appreciate disclosure. You know that you are not Fuzzburg 09/15/18 12:06:21 PM
#11624   I follow this stock pretty close and sometimes Kizersosae 09/14/18 07:54:34 PM
#11623   Yes I did. Kizersosae 09/14/18 07:20:15 PM
#11622   Kizer I thought you already sold all off Fuzzburg 09/14/18 07:16:00 PM
#11621   Understood...ugh msw1221 09/14/18 04:42:10 PM
#11620   Ya but we don’t have the grant yet. Kizersosae 09/14/18 03:01:24 PM
#11619   I thought I understood that the grant AND msw1221 09/14/18 02:52:06 PM
#11618   The question that should be asked is what Kizersosae 09/14/18 02:40:50 PM
#11617   I guess I agree... but we now have msw1221 09/14/18 01:49:40 PM
#11616   I don’t think so. BICX applied for a Kizersosae 09/14/18 03:59:17 AM
#11615   Is it possible that the grant awards are msw1221 09/13/18 10:36:31 PM
#11614   Dont seem rite does it lol Nathans123 09/13/18 11:22:12 AM
#11613   Not trading today? msw1221 09/13/18 10:58:31 AM
#11612   Easiest double I’ve seen lol Kizersosae 09/12/18 09:59:38 PM
#11610   How did someone get lucky at 5 cents? msw1221 09/12/18 02:57:44 PM
#11609   Big volume today. Something is up. stenz902 09/12/18 01:06:42 PM
#11608   I’m okay with that! I’ve been holding Joshthebeast24 09/12/18 11:18:42 AM
#11607   https://www.nasdaq.com/press-release/actor-jeremy-miller-appears-on-local-abc-ne 74 09/12/18 11:15:57 AM
#11606   https://www.nasdaq.com/press-release/actor-jeremy-miller-appears-on-local-abc-ne 74 09/12/18 11:15:10 AM
#11605   https://ir.biocorrx.com/press-releases/detail/135 I would imagine the Investors who bought $1.1 Swisher27 09/12/18 08:23:44 AM
#11604   At this point does it really matter when Kizersosae 09/12/18 07:06:22 AM
#11603   I'm not sure they'd time it in that Swisher27 09/12/18 06:56:03 AM
#11602   So there is a chance that it got Joshthebeast24 09/12/18 12:35:31 AM
#11601   Press Release Aug/07/2018: Swisher27 09/11/18 11:55:25 PM
#11600   That is highly likely. If a grant big orange 09/11/18 08:36:08 PM
#11599   We're taking a beating today..need some good news Nathans123 09/11/18 03:34:48 PM
#11598   Is it possible we didn’t get the grant? msw1221 09/11/18 03:07:37 PM
#11597   No new news. If u cannot wait Fuzzburg 09/11/18 02:01:34 PM
#11596   Oh wow... Big drop... Nathans123 09/11/18 01:30:55 PM
#11595   Looks like this is a resource to keep msw1221 09/10/18 03:59:54 PM
#11594   I have a feeling this is the week. Pip611 09/10/18 06:37:48 AM
#11593   Hopefully good news out this week, should move JB51 09/09/18 08:29:22 PM
#11592   Aaaaaaaaaany day now... msw1221 09/07/18 01:55:31 PM
PostSubject